China SXT Pharmaceuticals... (SXTC)
NASDAQ: SXTC
· Real-Time Price · USD
1.60
0.02 (1.27%)
At close: Aug 15, 2025, 3:59 PM
1.60
0.00%
After-hours: Aug 15, 2025, 07:44 PM EDT
China SXT Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 18.1M | 18.51M | 18.51M | 12.07M | 12.07M | 11.47M | 11.47M | 17.37M | 17.37M | 2.98M | 2.98M | 15.52M | 15.52M | 31.32K | 31.32K | 13.33M | 13.33M | 10.35M | 10.35M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -530.37K | n/a |
Other Long-Term Assets | n/a | 8.55M | 8.55M | 8.31M | 8.31M | n/a | n/a | 8.74M | 8.74M | 8.43M | 8.43M | 9.46M | 9.46M | 9.31M | 9.31M | 9.16M | 9.48M | 530.37K | 23.37K |
Receivables | 1.9M | 1.66M | 1.66M | 1.31M | 1.31M | 1.31M | 1.31M | 1.58M | 1.34M | 3.32M | 3.32M | 3.37M | 3.37M | 10.06M | 3.88M | 7.77M | 4.51M | 9.53M | 5.58M |
Inventory | 828.05K | 1.59M | 1.59M | 794.86K | 809.76K | 581.32K | 581.32K | 531.25K | 577.56K | 628.19K | 686.31K | 1.02M | 1.07M | 837.45K | 1.37M | 859.7K | 1.38M | 867.28K | 1.35M |
Other Current Assets | 30.41K | 223.01K | 223.01K | 6.84K | 38.48K | 49.88K | 137.98K | -46.3K | 230.64K | 583.15K | 5.37M | 2.58M | 2.49M | 6.38M | 6.38M | 4.01M | 4.01M | 4.78M | 4.78M |
Total Current Assets | 21.3M | 21.99M | 21.99M | 14.23M | 14.23M | 13.5M | 13.5M | 19.52M | 19.52M | 12.36M | 12.36M | 22.45M | 22.45M | 11.66M | 11.66M | 23.23M | 23.23M | 22.06M | 22.06M |
Property-Plant & Equipment | 355.21K | 443.21K | 443.21K | 564.69K | 564.69K | 1.07M | 1.07M | 1.27M | 1.27M | 1.36M | 1.36M | 1.59M | 1.59M | 1.65M | 1.65M | 1.79M | 1.79M | 1.91M | 1.91M |
Goodwill & Intangibles | 11.81K | 15.9K | 15.9K | 19.1K | 19.1K | 22.51K | 22.51K | 27.87K | 27.87K | 30.72K | 30.72K | 38.76K | 38.76K | 42.35K | 42.35K | 45.8K | 45.8K | 48.2K | 48.2K |
Total Long-Term Assets | 367.02K | 9.01M | 9.01M | 8.89M | 8.89M | 1.09M | 1.09M | 10.03M | 10.03M | 9.82M | 9.82M | 11.09M | 11.09M | 11.01M | 11.01M | 11.31M | 11.31M | 1.98M | 1.98M |
Total Assets | 21.66M | 31M | 31M | 23.13M | 23.13M | 14.59M | 14.59M | 29.55M | 29.55M | 22.18M | 22.18M | 33.55M | 33.55M | 22.67M | 22.67M | 34.55M | 34.55M | 24.04M | 24.04M |
Account Payables | 1.16M | 1.66M | 1.66M | 1.28M | 1.28M | 1.32M | 1.32M | 1.38M | 1.38M | 1.56M | 1.56M | 1.48M | 1.48M | 1.49M | 1.49M | 1.46M | 1.46M | 1.36M | 1.36M |
Deferred Revenue | 58.63K | n/a | n/a | 1.05M | 1.65M | 190.19K | n/a | 165.53K | n/a | 65.1K | n/a | 77.37K | n/a | 218.64K | n/a | 257.45K | n/a | 217.41K | n/a |
Short-Term Debt | 710.97K | 9.54M | 9.54M | 2.29M | 3.34M | 2.78M | 3.2M | 3.33M | 8.54M | 1.21M | 1.21M | 2.05M | 10.74M | 24.04K | 2.14M | 37.12K | 12.19M | 45.76K | 45.76K |
Other Current Liabilities | 728.28K | 2.71M | 2.71M | 2.63M | 2.63M | 2.97M | 2.54M | 7.99M | 2.79M | 2.95M | 2.58M | 122.77K | 2.89M | 5.96M | 3.36M | 1.29M | 3.42M | 3.58M | 3.04M |
Total Current Liabilities | 6.01M | 15.66M | 15.66M | 8.9M | 8.9M | 9.2M | 9.2M | 14.5M | 14.5M | 7.29M | 7.29M | 17.12M | 17.12M | 8.88M | 8.88M | 18.58M | 18.58M | 5.51M | 5.51M |
Long-Term Debt | 96.26K | 115.34K | 115.34K | 117.13K | 117.13K | 106.58K | 106.58K | 117.86K | 117.86K | n/a | n/a | n/a | n/a | n/a | n/a | 6.29K | 6.29K | 15.21K | 15.21K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 211.68K | 298.01K | 298.01K | 294.67K | 294.67K | 311.51K | 311.51K | 365.82K | 365.82K | 2.83M | n/a | 3.61M | n/a | n/a | n/a | 6.29K | 6.29K | 15.21K | 15.21K |
Total Liabilities | 6.22M | 15.96M | 15.96M | 9.2M | 9.2M | 9.51M | 9.51M | 14.86M | 14.86M | 7.29M | 7.29M | 17.12M | 17.12M | 8.88M | 8.88M | 18.59M | 18.59M | 5.52M | 5.52M |
Total Debt | 983.88K | 9.87M | 9.87M | 2.65M | 3.46M | 3.15M | 3.52M | 3.76M | 8.9M | 1.21M | 1.21M | 2.05M | 10.74M | 24.04K | 2.14M | 43.41K | 12.19M | 60.97K | 60.97K |
Common Stock | 44.53M | 7.73M | 7.73M | 4.35M | 4.35M | 1.45M | 1.45M | 913.78K | 913.78K | 288.08K | 288.08K | 162.47K | 162.47K | 67.44K | 67.44K | 62.06K | 62.06K | 62.06K | 62.06K |
Retained Earnings | -28.02M | -25.51M | -25.51M | -24.71M | -24.71M | -31.31M | -31.31M | -21.61M | -21.61M | -17.18M | -17.18M | -15.69M | -15.69M | -13.04M | -13.04M | -9.95M | -9.95M | -5.82M | -5.82M |
Comprehensive Income | -1.08M | -568.85K | -568.85K | -1.03M | -1.03M | -1.02M | -1.02M | -197.57K | -197.57K | -779.39K | -779.39K | 956.14K | 956.14K | 758.82K | 758.82K | 527.79K | 527.78K | 48.12K | 48.12K |
Shareholders Equity | 15.44M | 15.03M | 15.03M | 13.93M | 13.93M | 5.08M | 5.08M | 14.69M | 14.69M | 14.89M | 14.89M | 16.42M | 16.42M | 13.79M | 13.79M | 15.96M | 15.96M | 18.52M | 18.52M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -530.37K | n/a |